Regional trends in suspected synthetic cannabinoid exposure from January 2016 to September 2019 in the United States.

ABSTRACT:

Background

The unpredictable physiologic and pharmacologic effects of synthetic cannabinoids (SCs) are continuously changing as the chemical structure of SCs evolve to avoid classification as a Schedule I drug under the Controlled Substances Act in the U.S. This results in unpredictable pharmacologic effects and subsequent sequelae. Little is known about national or regional trends of SC clusters. The objective of this study is to investigate trends in SC exposure using emergency department (ED) syndromic data.

Methods

We analyzed ED syndromic data to detect quarterly trends from January 2016 through September 2019 for SC-related exposures within 59 jurisdictions in 47 states by U.S. region. Pearson chi-square tests detected quarter-to-quarter changes and Joinpoint regressio

SUBMITTER: Roehler DR 

PROVIDER: S-EPMC9590641 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature